[suzierose]

Less is More for High Risk multiple myeloma Cytogenetic Patients

by suzierose on Fri Jan 27, 2012 5:55 pm

A provocative analysis suggests that a sequence of two novel agents provides a better survival advantage than regimens with three or more agents in patients with multiple myeloma and high-risk cytogenetics......snip

Notably, patients with high-risk cytogenetics had significantly worse survival if they received intensive therapy rather than nonintensive therapy (median 44 months vs. 72 months; P = .01), he noted. In contrast, patients without high-risk cytogenetics had similar overall survival regardless of whether they belonged to the intensive therapy or nonintensive therapy groups (median 76 months vs. 75 months).

http://www.oncologystat.com/news/Less_May_Be_More_in_Treating_High-Risk_Myeloma_US.html

[Lisa B.]

Re: Less is More for High Risk multiple myeloma Cytogenetic

by Lisa B. on Fri Jan 27, 2012 9:53 pm

This is very interesting!! As always, THANK YOU, Suzierose, for sharing the fruits of your amazing research skills!!